- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 16 x K: POTASSIUM ION(Non-covalent)
K.2: 15 residues within 4Å:- Chain B: G.391, Y.392
- Chain D: G.391, Y.392
- Chain F: G.391, Y.392
- Chain H: G.391, Y.392
- Ligands: K.3, K.8, K.9, K.14, K.15, K.20, K.21
Ligand excluded by PLIPK.3: 19 residues within 4Å:- Chain B: V.390, G.391
- Chain D: V.390, G.391
- Chain F: V.390, G.391
- Chain H: V.390, G.391
- Ligands: K.2, K.4, K.8, K.9, K.10, K.14, K.15, K.16, K.20, K.21, K.22
Ligand excluded by PLIPK.4: 19 residues within 4Å:- Chain B: T.389, V.390
- Chain D: T.389, V.390
- Chain F: T.389, V.390
- Chain H: T.389, V.390
- Ligands: K.3, K.5, K.9, K.10, K.11, K.15, K.16, K.17, K.21, K.22, K.23
Ligand excluded by PLIPK.5: 11 residues within 4Å:- Chain B: T.389
- Chain D: T.389
- Chain F: T.389
- Chain H: T.389
- Ligands: K.4, K.10, K.11, K.16, K.17, K.22, K.23
Ligand excluded by PLIPK.8: 15 residues within 4Å:- Chain B: G.391, Y.392
- Chain D: G.391, Y.392
- Chain F: G.391, Y.392
- Chain H: G.391, Y.392
- Ligands: K.2, K.3, K.9, K.14, K.15, K.20, K.21
Ligand excluded by PLIPK.9: 19 residues within 4Å:- Chain B: V.390, G.391
- Chain D: V.390, G.391
- Chain F: V.390, G.391
- Chain H: V.390, G.391
- Ligands: K.2, K.3, K.4, K.8, K.10, K.14, K.15, K.16, K.20, K.21, K.22
Ligand excluded by PLIPK.10: 19 residues within 4Å:- Chain B: T.389, V.390
- Chain D: T.389, V.390
- Chain F: T.389, V.390
- Chain H: T.389, V.390
- Ligands: K.3, K.4, K.5, K.9, K.11, K.15, K.16, K.17, K.21, K.22, K.23
Ligand excluded by PLIPK.11: 11 residues within 4Å:- Chain B: T.389
- Chain D: T.389
- Chain F: T.389
- Chain H: T.389
- Ligands: K.4, K.5, K.10, K.16, K.17, K.22, K.23
Ligand excluded by PLIPK.14: 15 residues within 4Å:- Chain B: G.391, Y.392
- Chain D: G.391, Y.392
- Chain F: G.391, Y.392
- Chain H: G.391, Y.392
- Ligands: K.2, K.3, K.8, K.9, K.15, K.20, K.21
Ligand excluded by PLIPK.15: 19 residues within 4Å:- Chain B: V.390, G.391
- Chain D: V.390, G.391
- Chain F: V.390, G.391
- Chain H: V.390, G.391
- Ligands: K.2, K.3, K.4, K.8, K.9, K.10, K.14, K.16, K.20, K.21, K.22
Ligand excluded by PLIPK.16: 19 residues within 4Å:- Chain B: T.389, V.390
- Chain D: T.389, V.390
- Chain F: T.389, V.390
- Chain H: T.389, V.390
- Ligands: K.3, K.4, K.5, K.9, K.10, K.11, K.15, K.17, K.21, K.22, K.23
Ligand excluded by PLIPK.17: 11 residues within 4Å:- Chain B: T.389
- Chain D: T.389
- Chain F: T.389
- Chain H: T.389
- Ligands: K.4, K.5, K.10, K.11, K.16, K.22, K.23
Ligand excluded by PLIPK.20: 15 residues within 4Å:- Chain B: G.391, Y.392
- Chain D: G.391, Y.392
- Chain F: G.391, Y.392
- Chain H: G.391, Y.392
- Ligands: K.2, K.3, K.8, K.9, K.14, K.15, K.21
Ligand excluded by PLIPK.21: 19 residues within 4Å:- Chain B: V.390, G.391
- Chain D: V.390, G.391
- Chain F: V.390, G.391
- Chain H: V.390, G.391
- Ligands: K.2, K.3, K.4, K.8, K.9, K.10, K.14, K.15, K.16, K.20, K.22
Ligand excluded by PLIPK.22: 19 residues within 4Å:- Chain B: T.389, V.390
- Chain D: T.389, V.390
- Chain F: T.389, V.390
- Chain H: T.389, V.390
- Ligands: K.3, K.4, K.5, K.9, K.10, K.11, K.15, K.16, K.17, K.21, K.23
Ligand excluded by PLIPK.23: 11 residues within 4Å:- Chain B: T.389
- Chain D: T.389
- Chain F: T.389
- Chain H: T.389
- Ligands: K.4, K.5, K.10, K.11, K.16, K.17, K.22
Ligand excluded by PLIP- 4 x PGW: (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate(Non-covalent)
PGW.6: 9 residues within 4Å:- Chain B: I.347, P.377, D.378, F.380, W.381, V.384
- Chain H: I.400, K.403, S.407
6 PLIP interactions:3 interactions with chain B, 3 interactions with chain H- Hydrophobic interactions: B:I.347, B:F.380, B:W.381
- Hydrogen bonds: H:K.403, H:K.403
- Salt bridges: H:K.403
PGW.12: 9 residues within 4Å:- Chain D: I.347, P.377, D.378, F.380, W.381, V.384
- Chain F: I.400, K.403, S.407
6 PLIP interactions:3 interactions with chain D, 3 interactions with chain F- Hydrophobic interactions: D:I.347, D:F.380, D:W.381
- Hydrogen bonds: F:K.403, F:K.403
- Salt bridges: F:K.403
PGW.18: 9 residues within 4Å:- Chain B: I.400, K.403, S.407
- Chain F: I.347, P.377, D.378, F.380, W.381, V.384
6 PLIP interactions:3 interactions with chain F, 3 interactions with chain B- Hydrophobic interactions: F:I.347, F:F.380, F:W.381
- Hydrogen bonds: B:K.403, B:K.403
- Salt bridges: B:K.403
PGW.24: 9 residues within 4Å:- Chain D: I.400, K.403, S.407
- Chain H: I.347, P.377, D.378, F.380, W.381, V.384
6 PLIP interactions:3 interactions with chain H, 3 interactions with chain D- Hydrophobic interactions: H:I.347, H:F.380, H:W.381
- Hydrogen bonds: D:K.403, D:K.403
- Salt bridges: D:K.403
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Long, S.B. et al., Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature (2007)
- Release Date
- 2007-11-20
- Peptides
- Voltage-gated potassium channel subunit beta-2: ACEG
Paddle chimera voltage gated potassium channel Kv1.2-Kv2.1: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GC
GE
GG
GB
HD
HF
HH
H - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 16 x K: POTASSIUM ION(Non-covalent)
- 4 x PGW: (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Long, S.B. et al., Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment. Nature (2007)
- Release Date
- 2007-11-20
- Peptides
- Voltage-gated potassium channel subunit beta-2: ACEG
Paddle chimera voltage gated potassium channel Kv1.2-Kv2.1: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GC
GE
GG
GB
HD
HF
HH
H - Membrane
-
We predict this structure to be a membrane protein.